Trials / Unknown
UnknownNCT05268406
Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Check-Cap Ltd. · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the first part of the study (subgroup R\&D) is to demonstrate the safety and performance of the C-Scan system and to collect data in order to improve the analysis process. The purpose of the second part of the study (subgroup pre-pivotal) is to determine the ability of the C-Scan System to identify elevated risk subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | C-Scan System | Subjects will be provided with contrast agent and dietary fiber pills, and instructed to start intake approximately 48 hours prior to the planned C-Scan procedure start. C-Scan system intervention includes ingestion of the C-Scan Cap and attachment of the C-Scan track to the subject's lower back. The subject is required to keep the C-Scan Track attached to the lower back and to continue intake of contrast agent and dietary fiber pills until the C-Scan Cap's natural excretion. Standard of care optical colonoscopy will be performed within 60 days from the C-Scan Cap ingestion. |
Timeline
- Start date
- 2020-07-29
- Primary completion
- 2023-05-31
- Completion
- 2023-08-31
- First posted
- 2022-03-07
- Last updated
- 2022-12-08
Locations
10 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT05268406. Inclusion in this directory is not an endorsement.